Email this article 
Post a Comment 
Hyaluronan-mediated ferric oxide nanoparticles causes apoptosis of CD44 expressing head and neck squamous cell carcinoma cells
Abstract
Purpose: To eliminate CD44, a putative cancer stem cell (CSC) marker, overexpressing head and neck squamous cell carcinoma (HNSCC) cells by using hyaluronan-conjugated, dextran-coated super paramagnetic iron oxide nanoparticles (HA-DESPIONs), in conjunction with induced heat produced by exposure to an alternating magnetic field (AMF).
Methods: An AMF generator was constructed by means of a solenoid coil and an impedance circuit driven by a power amplifier. A signal generator produced a small sinusoidal signal of 130 kHz that was then amplified to 9 A (peak to peak value) to generate an AMF of approximately 10 kA/m (12.6 mT) at the center of a coil. The heat generating effect of the AMF generator was tested via several kinetic and dose-dependent bulk heating experiments by exposing readily available magnetic nanoparticles to AMF. For elimination of CD44 population, UT-SCC-14 cells were exposed to either targeted HA-DESPIONs or non-targeted DESPIONs at a concentration 200 μg/ml and exposed to AMF for 30 minutes. Cells were processed after 24 hours for flow cytometry based analysis of apoptosis.
Results: Magnetic nanoparticles caused a concentration-dependent bulk heating effect in response to AMF resulting in a significant temperature rise. Following the exposure to AMF, non-conjugated DESPIONs were unable to induce targeted hyperthermia and hence had no effect on CD44 cell death in HNSCC cells. However, there was a significant cell death in the CD44 population treated with HA-DESPIONs and exposed to AMF. This effect was only obeserved when the magnetic field was turned on.
Conclusion: Bulk heating experiments concluded that a simple AMF generator was able to activate magnetic nanoparticles and flow cytometry demonstrated that HA- DESPIONs were able to cause apoptosis in UT-SCC-14 cells that express CD44.This may be a promising strategy to specifically target cancer stem cells (CSCs) for the treatment of HNSCC.
Keywords
Full Text:
PDFReferences
Vermorken JB, Remenar E, van Herpen C, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med. 2007;357(17):1695-704.
Pignon JP, le Maître A, Maillard E, et al. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol. 2009 Jul;92(1):4-14.
Reya T, Morrison SJ, Clarke MF, Weissman IL. Stem cells, cancer, and cancer stem cells. Nature. 2001;414(6859):105-11.
Prince ME, Sivanandan R, Kaczorowski A, et al. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A. 2007;104(3):973-8.
Wang SJ, Wong G, de Heer AM, et al. CD44 Variant isoforms in head and neck squamous cell carcinoma progression. Laryngoscope. 2009;119(8):1518-30.
Toole BP, Slomiany MG. Hyaluronan, CD44 and Emmprin: partners in cancer cell chemoresistance. Drug Resist Updat. 2008;11(3):110-21.
Laurent TC, Laurent UB, Fraser JR. The structure and function of hyaluronan: An overview. Immunol Cell Biol. 1996;74(2):A1-7.
Bartolazzi A, Peach R, Aruffo A, Stamenkovic I. Interaction betwenn CD44 and hyaluronate is directly implicated in the regulation of tumor-development. J Exp Med. 1994;180(1):53-66.
Liu W, Frank JA. Detection and quantification of magnetically labeled cells by cellular MRI. Eur J Radiol. 2009;70(2):258-64.
Dixon WT, Blezek DJ, Lowery LA, et al. Estimating amounts of iron oxide from gradient echo images. Magn Reson Med. 2009;61(5):1132-6.
Ang KK, Andratschke NH, Milas L. Epidermal growth factor receptor and response of head-and-neck carcinoma to therapy. Int J Radiat Oncol Biol Phys. 2004;58(3):959-65.
Zhao Q, Wang LN, Cheng R, et al. Magnetic nanoparticle-based hyperthermia for head & neck cancer in mouse models. Theranostics. 2012;2(1):113-21.
Drake P, Cho H-J, Shih P-S, Kao C-H, Lee K-F, Kuo C-H, et al. Gd-doped iron-oxide nanoparticles for tumour therapy via magnetic field hyperthermia. J Mater Chem. 2007;17(46):4914-8.
Smolkova IS, Kazantseva NE, Babayan V, Smolka P, Parmar H, Vilcakova J, et al. Alternating magnetic field energy absorption in the dispersion of iron oxide nanoparticles in a viscous medium. J Magn Magn Mater. 2015;374:508-15.
Thomas LA, Dekker L, Kallumadil M, Southern P, Wilson M, Nair SP, et al. Carboxylic acid-stabilised iron oxide nanoparticles for use in magnetic hyperthermia. J Mater Chem. 2009;19(36):6529-35.
Muller S. Magnetic fluid hyperthermia therapy for malignant brain tumors-an ethical discussion. Nanomedicine. 2009;5(4):387-93.
Provenzale JM, Silva GA. Uses of Nanoparticles for Central Nervous System Imaging and Therapy. AJNR Am J Neuroradiol. 2009;30(7):1293-301.
Thapa R, Galoforo S, Kandel SM, El-dakdouki MH, Wilson TG, Huang X, et al. Radiosensitizing and hyperthermic properties of hyaluronan conjugated, dextran-coated ferric oxide nanoparticles: Implications for cancer stem cell therapy. J Nanomater. 2015; 2015:840594.
El-Dakdouki MH, Zhu DC, El-Boubbou K, et al. Development of multifunctional hyaluronan-coated nanoparticles for imaging and drug delivery to cancer cells. Biomacromolecules. 2012;13(4):1144-51.
El-Dakdouki MH, El-Boubbou K, Kamat M, et al. CD44 Targeting magnetic glyconanoparticles for atherosclerotic plaque imaging. Pharm Res. 2014;31(6):1426-37.
Wilson GD, Marples B, Galoforo S, et al. Isolation and genomic characterization of stem cells in head and neck cancer. Head Neck. 2013;35(11):1573-82.
Kamat M, El-Boubbou K, Zhu DC, Lansdell T, Lu X, Li W, et al. Hyaluronic acid immobilized magnetic nanoparticles for active targeting and imaging of macrophages. Bioconjug Chem. 2010;21(11):2128-35.
El-Boubbou K, Zhu DC, Vasileiou C, Borhan B, Prosperi D, Li W, et al. Magnetic glyco-nanoparticles: a tool to detect, differentiate, and unlock the glyco-codes of cancer via magnetic resonance imaging. J Am Chem Soc. 2010;132(12):4490-9.
El-Dakdouki MH, El-Boubbou K, Zhu DC, Huang X. A simple method for the synthesis of hyaluronic acid coated magnetic nanoparticles for highly efficient cell labelling and in vivo imaging. Rsc Adv. 2011;1(8):1449-52.
Thapa R, Wilson GD. Head and neck cancer: Current treatment options and associated challenges. Sch J App Med Sci. 2016;4(2D):590-600.
Thapa R, Wilson GD. The importance of CD44 as a stem cell biomarker and therapeutic target in cancer. Stem Cells Int. 2016;2016:2087204.
Thomas RG, Moon MJ, Lee H, et al. Hyaluronic acid conjugated superparamagnetic iron oxide nanoparticle for cancer diagnosis and hyperthermia therapy. Carbohydr Polym. 2015;131:439-46.
Singh N, Jenkins GJS, Asadi R, Doak SH. Potential toxicity of superparamagnetic iron oxide nanoparticles (SPION). Nano Rev. 2010;1.
Wabler M, Zhu W, Hedayati M, et al. Magnetic resonance imaging contrast of iron oxide nanoparticles developed for hyperthermia is dominated by iron content. Int J Hyperthermia. 2014;30(3):192-200.
Wilson GD, Thibodeau BJ, Fortier LE, et al. Cancer Stem Cell Signaling during Repopulation in Head and Neck Cancer. Stem Cells Int. 2016;2016:1894782.
Yee S, Ionascu D, Thapa R, Wilson GD. An exploratory RF pulse sequence technique used to induce differential heating in tissues containing iron oxide nanoparticles for a possible hyperthermic adjuvant effect to radiotherapy. Med Phys. 2014;41:356.
DOI: http://dx.doi.org/10.14319/ijcto.42.4
This work is licensed under a Creative Commons Attribution 3.0 License.
International Journal of Cancer Therapy and Oncology (ISSN 2330-4049)
© International Journal of Cancer Therapy and Oncology (IJCTO)
To make sure that you can receive messages from us, please add the 'ijcto.org' domain to your e-mail 'safe list'. If you do not receive e-mail in your 'inbox', check your 'bulk mail' or 'junk mail' folders.
Number of visits since October, 2013